Key facts
- This page summarizes Scott Minick's Form 4 filing for CHIASMA, INC.
- 7 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 05 Aug 2021, 17:58.
Scott Minick - 05 Aug 2021 Form 4 Insider Report for CHIASMA, INC
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 05 Aug 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Lee G. Giguere, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Scott Minick filed Form 4 for CHIASMA, INC on 05 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CHMA
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -87,194
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Aug 2021
- Ownership
- See Footnote 2
- Footnotes
- F1, F2, F3
CHMA
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -62,531
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CHMA
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -10,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $3.14
- Footnotes
- F1, F4
CHMA
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -13,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,000
- Exercise price
- $1.35
- Footnotes
- F1, F4
CHMA
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -13,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,000
- Exercise price
- $1.45
- Footnotes
- F1, F4
CHMA
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -13,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,000
- Exercise price
- $7.98
- Footnotes
- F1, F4
CHMA
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -13,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,000
- Exercise price
- $5.81
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Scott Minick is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 4 footnotes
Footnote F1
This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated as of May 4, 2021, by and among Chiasma, Inc. (the "Company), Amryt Pharma plc ("Parent"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent ("Merger Sub") pursuant to which Merger Sub merged with and into the Company (the "Merger") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the "Effective Time").
Footnote F2
At the Effective Time, each share of common stock of the Company (each, a "Share") (excluding any Shares held in the treasury of the Company or owned, directly or indirectly, by Parent or Merger Sub immediately prior to the Effective Time) was cancelled and converted into the right to receive 0.396 (the "Exchange Ratio") American Depositary Shares of Parent ("Parent ADS") representing five ordinary shares of Parent.
Footnote F3
60,000 shares are directly held by the Mt. Rose Trust ("MRT") and 27,194 shares are directly held by the Minick Family Trust ("MFT"). The Reporting Person is the co-trustee of MRT and MFT and disclaims beneficial ownership of all the shares except to the extent of his pecuniary interest, if any, therein.
Footnote F4
At the Effective Time, each option to purchase Shares (each a "Company Option") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an "Assumed Stock Option") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio.